Check-Cap Ltd. (MBAI:NASDAQ) closed at $1.95 on October 26, 2026, down 5.57% on the day. The stock trades 92.9% below its 52-week high of $27.44 and 5.7% above its 52-week low of $1.85. Check-Cap Ltd. is part of the Health Care sector.
In 252 trading sessions since October 24, 2025, MBAI closed higher on 101 days (40%). Its best day was March 9, 2026 (+655.06%) and its worst was January 27, 2026 (-27.22%). The stock moved 10% or more in a single session 32 times. It opened at least 5% above the previous day's high 2 times.
Check-Cap Ltd is a clinical-stage medical diagnostics company engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The company is developing C-Scan, the first capsule-based system for preparation-free, colorectal cancer screening. Its scanning capsule will be swallowed and propelled by natural motility through the gastrointestinal tract and excreted naturally with no need for retrieval for data collection.
Find more stocks like MBAI with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.